attenuated measles vaccine - Edmonston strain

Trade name: rubeovax

Vaccinewithdrawn

Approved

Mar 1, 1963

Clinical trial activity

25 trials · 40 clinical orgs · 1 marketing orgs

Phase 1
4
Phase 2
5
Phase 3
3
Phase 4
14

Earliest trial started Nov 2, 1999 (NCT00000815)

Timeline

1960s

  1. Mar 1, 1963

    Earliest FDA Approval

  2. Mar 21, 1963

    Merck — First NDA Organization

  3. Mar 21, 1963

    Merck — NDA Secondary Org

  4. Mar 21, 1963

    Merck — NDA Organization

1990s

  1. Jan 1, 1999

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Approval history

  • withdrawnMar 1, 1963

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • attenuated measles vaccine
  • attenuvax
  • attenuvax
  • attenuvax
  • measles, live attenuated
  • measles vaccine
  • measles virus vaccine
  • measles virus vaccine live
  • rubeola (measles) vaccine, live attenuated
  • rubeola (measles) vaccine, live, attenuated
  • rubeola (measles) vaccine, live further attenuated
  • rubeovax

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05794230Phase 3Mar 27, 2023Sanofi-Aventis
NCT04899765Phase 4May 20, 2021Bandim Health Project, Free University of Brussels, University of Southern Denmark, University of Western Australia
NCT04220671Phase 4Jan 31, 2020Bandim Health Project
NCT03296410Phase 4Sep 14, 2017Chinese Academy of Medical Sciences, Government of China
NCT03330171Phase 4Apr 10, 2017University of the Witwatersrand
NCT03170765N/AMar 14, 2017Postgraduate Institute of Medical Education and Research
NCT03460002Phase 4Nov 30, 2016Bandim Health Project, Statens Serum Institut
NCT02962167Phase 1Nov 1, 2016Mayo Clinic, No More Kids With Cancer, The Matthew Larson Foundation for Pediatric Brain Tumors, University of California, San Francisco, Vyriad, Inc.
NCT02943681N/AOct 1, 2016Bandim Health Project
NCT02196285Phase 1Sep 1, 2015Bill and Melinda Gates Foundation, Oswaldo Cruz Foundation
NCT02286895Phase 4Oct 1, 2014Centre for Vaccine Development, Mali, PATH, University of Maryland
NCT01668745Phase 4May 1, 2013Bandim Health Project, Centre de Recherche en Sante de Nouna, Burkina Faso, National Institute for Public Health and the Environment, RIVM, Holland, Navrongo Health Research Centre, Ghana, University of Heidelberg
NCT01644721Phase 4Jul 1, 2012Bandim Health Project, Centre de Recherche en Sante de Nouna, Burkina Faso, National Institute for Public Health and the Environment, RIVM, Holland, Navrongo Health Research Centre, Ghana, University of Heidelberg
NCT01557699Phase 1Mar 1, 2012Centers for Disease Control and Prevention (CDC), Dr. D. Y. Patil Dental College & Hospital, Serum Institute of India Pvt. Ltd., University of Colorado, Boulder
NCT01345240Phase 3Nov 1, 2011GlaxoSmithKline
NCT01486355Phase 4Aug 1, 2011Bandim Health Project
NCT02724852Phase 4Jul 1, 2011Chiangmai University
NCT01306006Phase 4Feb 1, 2011Bandim Health Project, Institudo Nacional de Saude Publica INASA
NCT00828022Phase 1/Phase 2 (Phase 2)Mar 1, 2009Ben Gurion University
NCT00829010Phase 3Feb 1, 2009GlaxoSmithKline
Showing 20 of 25 trials
Page 1 / 2

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bandim Health ProjectGovernment111122002
Medical Research Council, The GambiaGovernment4122002
Danish Council for Development ResearchGovernment3012002
Novo NordiskFor profit3012002
Centre de Recherche en Sante de Nouna, Burkina FasoAcademic/Hospital2012012
GlaxoSmithKlineFor profit2212009
National Institute for Public Health and the Environment, RIVM, HollandGovernment2012012
Navrongo Health Research Centre, GhanaAcademic/Hospital2012012
University of HeidelbergAcademic/Hospital2012012
AP Moeller FoundationAcademic/Hospital1012003
Ben Gurion UniversityAcademic/Hospital1112009
Bill and Melinda Gates FoundationAcademic/Hospital1012015
Centers for Disease Control and Prevention (CDC)Government1012012
Centre for Vaccine Development, MaliAcademic/Hospital1012014
Chiangmai UniversityAcademic/Hospital1112011
Chinese Academy of Medical SciencesAcademic/Hospital1112017
Dr. D. Y. Patil Dental College & HospitalAcademic/Hospital1012012
Free University of BrusselsAcademic/Hospital1012021
Government of ChinaGovernment1012017
Institudo Nacional de Saude Publica INASAAcademic/Hospital1012011
40 organizations
Page 1 / 2

Marketing (2)

OrganizationOrg typeRelationshipDate
MerckFor profitNDA2Mar 21, 1963
MerckFor profitNDAMar 21, 1963